Applicant, as named in the Orange Book

Famygen Life Sci

Next listed expiry: Ryzumvi on 25 Oct 2039. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ryzumvi phentolamine mesylate	phentolamine mesylate	217064	25 Oct 2039	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.